ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2352

Temporal Artery Biopsy Culture in Tridimensional Matrix. an in Vitro Model for Functional Studies in Giant-Cell Arteritis

Marc Corbera Bellalta1, Ester Planas Rigol1, Ester Lozano1, Marco A. Alba2, Itziar Tavera-Bahillo1, Sergio Prieto-González1, Georgina Espígol Frigolé1, Montserrat Butjosa1, José Hernández-Rodríguez1, Ana García-Martínez3 and Maria C. Cid4, 1Vasculitis Research Unit, Department of Systemic Autoimmune Diseases, Hospital Clinic University Barcelona, Barcelona, Spain, 2Systemic Autoimmune Diseases, Vasculitis Research Unit. Hospital Clínic. University of Barcelona. IDIBAPS, Barcelona, Spain, 3Department of Emergency Medicine, Vasculitis Research Unit. Hospital Clínic. University of Barcelona. IDIBAPS, Barcelona, Spain, 4Vasculitis Research Unit, Department of Autoimmune Diseases, Hospital Clínic University of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: cytokines, glucocorticoids, inflammation and vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Vasculitis

Session Type: Abstract Submissions (ACR)

Background/Purpose: GCA is the most frequent systemic vasculitis in Europe and North America. In spite of the initial response to glucocorticoid treatment more than 60% of patients relapse when glucocorticoids are tapered indicating the need for more effective therapies. Search for therapeutic targets in GCA is hampered by the lack of an animal model to assess the consequences of therapeutic intervention. Subcutaneous engraftment of temporal artery fragments into the SCID mice is the only existing functional system (Brack et al, J Clin Invest 1997) to assess the effects of intervention.  However it is costly, complex and only a limited number of conditions can be evaluated. We previously described a temporal artery culture model (Arthritis Rheum 2008 (suppl) 58:9; S929-S929), and the effects of the some cytokine blockade on cultured GCA arteries. Our purpose is to explore changes induced by corticosteroids on the expression of inflammatory mediators between control arteries, treatment naïve GCA arteries and GCA arteries treated with dexamethasone

Methods: Fresh temporal artery sections surgically removed for diagnoses purposes from 20 GCA patients and 18 controls were embedded in the reconstituted basement membrane MatrigelTM and cultured for 10 days as described (Arthritis Rheum 2008 (suppl) 58:9; S929-S929). Cultured sections were treated with medium alone or with medium supplemented with 0.5mg/ml of dexamethasone. IFNg, TNFα, IL-1β, IL-6, CD3, CD20 and CD68 mRNA were measured in recovered sections by quantitative real-time PCR (Applied Biosystems). Proinflammatory cytokine secretion was also measured in the supernatant fluid by immunoassay (R&D Systems)

Results: As expected, cultured inflamed arteries produced remarkable amounts of proinflammatory cytokine mRNAs (IFNg, TNFα, IL-1β, and IL-6) compared with control biopsies. Moreover, mRNA expression of CD3, CD20 and CD68 cell markers was significantly increased in biopsies from patients compared with controls. Glucocorticoid treatment of the GCA biopsies for 10 days markedly reduced mRNA expression of all cytokines and cell markers. At the protein level we found a significant decrease in IL-1β, TNFα and IL-6 which was less marked for IFNg. Our model reproduces previous results obtained in other functional systems or in cross-sectional or serial comparison of biopsies obtained from patient naïve versus treated patiens (Visvanathan S, Rheumatology 2011)

Conclusion: Our temporal artery culture system in tridimenional matrix is viable and is a suitable model to evaluate functional changes in biomarker expression and secretion after intervention. This model has several advantages compared with the SCID mice engraftment: it is simpler and cheaper, it allows continuous assessment of viability, the analysis of more conditions per specimen and the assessment of proteins in the supernatant fluid. Unfortunately, as in the SCID mice, disease outcomes cannot be assessed in our model.

Supported by SAF 08/04328 and SAF 11/30073


Disclosure:

M. Corbera Bellalta,
None;

E. Planas Rigol,
None;

E. Lozano,
None;

M. A. Alba,
None;

I. Tavera-Bahillo,
None;

S. Prieto-González,
None;

G. Espígol Frigolé,
None;

M. Butjosa,
None;

J. Hernández-Rodríguez,
None;

A. García-Martínez,
None;

M. C. Cid,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/temporal-artery-biopsy-culture-in-tridimensional-matrix-an-in-vitro-model-for-functional-studies-in-giant-cell-arteritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology